Tracking the source of heart failure
To treat heart problems, common sense says we should look to the heart. New European research based on an advanced ultrasound system suggests that stiffening of the arteries plays a key role
Cardiovascular diseases
Total artificial hearts and ventricular assist devices today
Artificial hearts, originally designed to bridge the time on the waiting list for a heart transplant, in recent years have increasingly become an independent treatment option for patients with chronic heart failure (HF). Interview: Bettina Döbereiner
Hearts in motion
Ultrasound is enthusiastically embraced by cardiologists in guidelines as essential for evaluating a patient's heart. Now visualisation of 3-D wall motion takes ultrasound to a higher level, opening a new understanding of heart mechanics
Toshiba presents advances in Cardiac Imaging at ESC 2012
Cardiology is playing an increasingly important role in today’s healthcare environment and, as a direct result, cardiologists are facing new challenges almost every day. Addressing the need of improving clinician confidence and diagnostic accuracy, Toshiba Medical Systems Europe presented two symposia on the first day of the European Congress of Cardiology, to be held in Munich, Germany, 25-28…
MRI brings a new beat to rhythmology
More anatomy details, real-time visualisation of catheter movement, and reduced exposure – MRI has promising potential in rhythmology, explain Professor Matthias Gutberlet and PD Dr Christopher Piorkowski, at the Heart Centre, University Hospital Leipzig, Germany.
Fame 2 rates FFR as a new gold standard
John Brosky reports on a ground-breaking trial and how CT-FFR may change the practice of invasive cardiology and cardiac surgery.
Teamwork works well in Hamburg
One heart – One Team, the motto for this year’s German Society for Thoracic and Cardiovascular Surgery Congress emphasises that cardiac surgeons and cardiologists must now work more in tandem for their mutual patients. This is not just a short-lived three-day slogan, but a daily reality at the University Heart Centre Hamburg, as EH correspondent Holger Zorn reports
Nanotechnology
Over the last five years the tiniest particles have attracted large attention in relation to the diagnosis and treatment of cardiovascular disease. Indeed, as in other medical disciplines, nanotechnology is advancing in cardiology despite as yet insufficient research on the extent of its effect and double blind studies to confirm findings
Learning from the deceased
The case-based approach holds considerable promise for medical science. In a way, it’s a return to the roots, since this approach was common at the dawn of modern medicine. A case serves as a narrative that can be explored interactively in order to draw a conclusion, determine a course of action, or debate issues in a realistic context. Spanish cardiac imaging consultant Dr Rafael Vidal Perez,…
Acute myocardial infarction
Could bone marrow cells prolong life? Recruitment of 3,000 patients will begin across the EU later this year for the BAMI (Bone Marrow Cells in Acute Myocardial Infarction) study, which will test whether stem cells taken from bone marrow and administered after a heart attack will prolong life. Mark Nicholls reports
Article • cTCA vs. cardiovascular diseases
CT coronary angiography
Cardiovascular diseases, the most common cause of death in the West, includes diseases for which early detection is an important objective in cardiac imaging – particularly for coronary artery stenosis. Diagnosis is often made in the cardiac catheter laboratory. Now, however, CT scanning advances provide a lower impact alternative to that invasive exam. PD Dr Thomas Schlosser, Consultant at the…
Advances in mitral valve replacement
Initially limited to the aortic valve, interventions are becoming routine for the mitral valve. Thus the only available product has enjoyed huge commercial success – until now. Report: Holger Zorn
Unnerved by denervation
Cardiologists are increasingly concerned about patients with persistent hypertension demanding a new technique, in the absence of clinical proof of its long-term benefit. As more related devices are launched, John Brosky reports on the procedure, drawbacks, and a potential €2 billion market.
The potent cardiac depressant in our own homes
Scientists state concern for both human and environmental health from a very commonly used antibacterial/antifungal agent. Brenda Marsh reports
CIED patients can have MRI examinations
A new generation of cardiovascular implantable electronic devices (CIEDs) includes the Implantable Cardioverter Defibrillator (ICD), Cardiac Resynchronisation Therapy Defibrillator (CRT-Ds) and Cardiac Resynchronisation Therapy Pacemakers (CRT-Ps). Professor W R Bauer at University Hospital Würzburg has been significantly involved in their development, EH Editor Ralf Mateblowski to ask him about…
A women's heart too often kills her
The biggest cause of death for most adult women in industrialised nations is coronary heart disease (CHD). Why the disease affects the genders differently is still not fully understood. European Hospital Editor Brigitte Dinkloh asked Professor Rafaelle Bugiardini MD FESC, from the Department of Internal Medicine Department, University of Bologna, whether he could explain the reasons and what…
Fatty Blood
Michael Rühl from the University of Greifswald, Working Group on Immunoadsorption and Cardiovascular Technology, describes therapies to tackle familial hypercholesterolemia
A heart for jellyfish
In a paper published in ”Nature Biotechnology” on the 22nd of July of 2012 Harvard researchers explain how making a jellyfish from rat DNA can help to solve cardiac problems.
Looking beyond the lungs: don’t forget the cardiac structures!
So close yet so far away! A fitting description of many diagnostic examinations of heart and lungs. Modern imaging modalities allow these two neighbouring organs to be evaluated together, nevertheless it is rarely done.
CT use increases for CAD diagnosis
Computed tomography (CT) has become central to the diagnosis and characterisation of coronary artery disease (CAD) and, in the future, could even supplant invasive coronary angiography as the technology increases sensitivity.
EuroPRevent 2012
CVD prevention experts will meet in Dublin from 3-5 May for the leading international forum for preventive cardiology, Finn Snyder reports.
The PARTNER Trial
Cohort A and B Results. Aortic stenosis is characterised by the hardening and narrowing of the aortic valve that pumps blood into the body’s main artery. It affects nearly 5% of those over 75 in Europe, with an estimated 16,000 Britons suffering from severe aortic stenosis.
The Symetis Acurate TA Aortic Bioprosthesis and delivery system
A new transcatheter aortic valve implantation (TAVI) system for transapical treatment of severe aortic stenosis – Acurate TA and delivery system –is a second- generation TAVI device to treat elderly patients. Launched by the Swiss firm Symetis SA, the system gained CE approval last September is on sale in Europe.
Art improves stroke survivors' quality of life
Stroke survivors who like art have a significantly higher quality of life than those who do not, according to new research. Patients who appreciated music, painting and theatre recovered better from their stroke than patients who did not.
Peripheral arterial occlusive disease Long balloons are the gold standard
Every year, around 80,000 lower extremities in Europe have to be (partially) amputated as a result of peripheral arterial occlusive disease (PAOD). Half of the affected patients die within five years of the amputation.